Share on StockTwits
 

Spectranetics Corp. (NASDAQ:SPNC) CFO Guy A. Childs sold 5,000 shares of the stock on the open market in a transaction that occurred on Thursday, February 6th. The stock was sold at an average price of $24.90, for a total transaction of $124,500.00. Following the completion of the sale, the chief financial officer now directly owns 138,945 shares in the company, valued at approximately $3,459,731. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

A number of analysts have recently weighed in on SPNC shares. Analysts at Zacks downgraded shares of Spectranetics Corp. from an “outperform” rating to a “neutral” rating in a research note to investors on Thursday. They now have a $28.50 price target on the stock. Separately, analysts at Northland Capital Partners downgraded shares of Spectranetics Corp. from a “market perform” rating to an “under perform” rating in a research note to investors on Monday. They now have a $20.00 price target on the stock. Finally, analysts at Northland Securities downgraded shares of Spectranetics Corp. from a “market perform” rating to an “underperform” rating in a research note to investors on Monday. They now have a $20.00 price target on the stock. They noted that the move was a valuation call. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $24.33.

Spectranetics Corp. (NASDAQ:SPNC) traded up 1.48% during mid-day trading on Friday, hitting $25.32. The stock had a trading volume of 282,701 shares. Spectranetics Corp. has a 1-year low of $15.52 and a 1-year high of $26.29. The stock has a 50-day moving average of $25.19 and a 200-day moving average of $20.56. The company’s market cap is $1.037 billion.

The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.